Director, Value Chain Management, Biotherapeutics (4 positions)
Johnson & Johnson is currently seeking a Director, Value Chain Management, Biotherapeutics for our Janssen Supply Group, LLC team!
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.
Innovative Medicines is a global organization responsible for supplying medicines to markets around the world. With Quality as their primary focus, this group strives to provide access and affordability through innovation and strong collaboration with their R&D and Commercial partners to deliver life changing solutions for patients in need.
Value Chain Lead – Launch and Growth, Biotherapeutics is accountable for activities, from Active Pharmaceutical Ingredient sourcing/production to Finished Goods distribution, related to strategic oversight and management of new biopharmaceutical products (brands) (from development through commercial optimization). This position will develop the IMSC product strategy, including crafting, updating, and executing the Product Strategic Roadmap (PSR >supply chain lifecycle management plan) for each product/brand in their portfolio. The role will lead the value management team for all IMSC activities and resources that are needed for this portfolio, including sourcing, cost-efficient tech transfer to commercial sites, the launch process in global commercial markets, dual sourcing/business continuity planning and ensuring supply sustainability, including next generations and line extensions, until the product/ brand is transferred to the Late-Stage Team.
Key Responsibilities:
The Value Chain Lead, Launch and Growth, Biotherapeutics will lead global, cross-functional, multidisciplinary Value Chain Teams (VCTs), with full accountability for:
- New product introduction strategy and execution in coordination with the Chemistry Manufacturing and Controls (CMC) & Global Commercial Teams (GCTs) assuring IMSC deliverables to accomplish CMC milestones are met.
- Initial sourcing of the product, and future sourcing sites as necessary
- The strategic direction for the brand relative to the supply chain, developing the Product Strategy Roadmap, preparing the business cases for Life Cycle Management (LCM) prioritization, articulating these business cases to stakeholders to secure funding, and assuring the approved LCM plan is executed by relevant parties within and outside IMSC.
- The identification, mitigation, and communication of supply chain related risks through the development, launch readiness, and product/process optimization stages.
- Ensuring the commercial strategy and customer needs are incorporated into the development of the launch strategy, product supply chain strategy, Product Strategy Roadmap (PSR)
- Championing commercialization of the best, optimized product, process, and supply chain at launch and ensuring integrated launch process is implemented.
- Assessing and optimizing product performance metrics (e.g. COGS, Cycle Time, trade-offs)
- Leading Issue Management Teams as necessary
- Building strong interdependent partnerships and run the communication effectively with key stakeholders in Discovery, Pharmaceutical Development and Supply (DPDS), and Innovative Medicine Supply Chain (IMSC), and our partners in the Commercial and Global Strategic Development Organizations, in strong alliance with the IMSC Planning and Customer Management organization.
- Representing IMSC in CMC teams as well as in Compound Development Teams, Global Commercial Teams, Integrated Brand Value Teams, and Disease Area Strongholds